Ling Xu
- Molecular Biology
- Immunology top 5%
- Infectious Diseases top 5%
- Renewable Energy, Sustainability and the Environment top 10%
- Epidemiology
- Topics
- interferon and immune responses (17 papers)Immune Response and Inflammation (9 papers)COVID-19 Clinical Research Studies (6 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ling Xu
54 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 120
- Molecular Biology 501
- Immunology 473
- Infectious Diseases 287
- Renewable Energy, Sustainability and the Environment 164
- Epidemiology 142
Countries citing papers authored by Ling Xu
This map shows the geographic impact of Ling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xu more than expected).
Fields of papers citing papers by Ling Xu
This network shows the impact of papers produced by Ling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xu. The network helps show where Ling Xu may publish in the future.
Co-authorship network of co-authors of Ling Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xu. A scholar is included among the top collaborators of Ling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xu. Ling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 19 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 9 | |
| 8 | 18 | |
| 9 | 2 | |
| 10 | 18 | |
| 11 | 13 | |
| 12 | 116 | |
| 13 | 3 | |
| 14 | 15 | |
| 15 | 66 | |
| 16 | 19 | |
| 17 | 38 | |
| 18 | 4 | |
| 19 | 24 | |
| 20 | Inducing chitinase and #beta#-1，3-glucanase activities of melon by spraying inducer | 2 |
About Ling Xu
Ling Xu is a scholar working on Immunology, Infectious Diseases and Microbiology, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include interferon and immune responses (17 papers), Immune Response and Inflammation (9 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Immunology (473 citations), Infectious Diseases (287 citations) and Renewable Energy, Sustainability and the Environment (164 citations). Ling Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yong‐Gang Yao, Dandan Yu, Yu Fan, Feng Wang, Wenshuai Wang, Anna Marie Pyle, Li Peng, Yong Wu, Yulin Yao and Anzhou Ma. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.